The Venture Codex

Participated · Series A · Aug 2025

Molecular You uses advanced proteomics and metabolomics to measure over 250 biomarkers from one blood sample, analyzing deep biological pathways to identify root-cause health risks across more than 25 health areas. Its AI-powered platform delivers personalized, actionable lifestyle recommendations for individuals and clinical practices, supporting preventive and precision medicine. The company has launched nationwide in both Canada and the United States through clinical practices and direct-to-consumer online channels. Molecular You partnered with HealthQuest Esoterics to run its current assay as a Lab Developed Test (LDT), making it eligible for reimbursement. The company plans a near-term introduction of a next-generation multi-omic assay that will measure over 800 biomarkers, broadening scope to additional areas including certain cancers. Leadership includes CEO Jim Kean and CMO Dr. Murdoc Khaleghi; the team has demonstrated clinical impact, including the rare, accurate detection of stage 1 pancreatic cancer that enabled early intervention.